Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1888
mi
from 98109
Sugar Land, TX
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1888
mi
from 98109
Sugar Land, TX
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1888
mi
from 98109
Sugar Land, TX
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1888
mi
from 98109
Sugar Land, TX
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1863
mi
from 98109
Tomball, TX
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1863
mi
from 98109
Tomball, TX
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1724
mi
from 98109
Waco, TX
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1724
mi
from 98109
Waco, TX
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
696
mi
from 98109
Bountiful, UT
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
696
mi
from 98109
Bountiful, UT
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
714
mi
from 98109
Draper, UT
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
714
mi
from 98109
Draper, UT
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
707
mi
from 98109
West Jordan, UT
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
707
mi
from 98109
West Jordan, UT
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2325
mi
from 98109
Alexandria, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2325
mi
from 98109
Alexandria, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2320
mi
from 98109
Arlington, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2320
mi
from 98109
Arlington, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2314
mi
from 98109
Burke, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2314
mi
from 98109
Burke, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2293
mi
from 98109
Danville, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2293
mi
from 98109
Danville, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2314
mi
from 98109
Mclean, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2314
mi
from 98109
Mclean, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2238
mi
from 98109
Salem, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2238
mi
from 98109
Salem, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2444
mi
from 98109
Virginia Beach, VA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2444
mi
from 98109
Virginia Beach, VA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
15
mi
from 98109
Port Orchard, WA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
15
mi
from 98109
Port Orchard, WA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
26
mi
from 98109
Tacoma, WA
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
26
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2155
mi
from 98109
Clarksburg, WV
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2155
mi
from 98109
Clarksburg, WV
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1646
mi
from 98109
Green Bay, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1646
mi
from 98109
Green Bay, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1681
mi
from 98109
Milwaukee, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1680
mi
from 98109
New Berlin, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1680
mi
from 98109
New Berlin, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1621
mi
from 98109
Oregon, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1621
mi
from 98109
Oregon, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1613
mi
from 98109
Verona, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1613
mi
from 98109
Verona, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1673
mi
from 98109
Waukesha, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1673
mi
from 98109
Waukesha, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1566
mi
from 98109
Weston, WI
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1566
mi
from 98109
Weston, WI
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
2467
mi
from 98109
Columbia, NC
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
2467
mi
from 98109
Columbia, NC
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
2341
mi
from 98109
Jalisco,
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
2341
mi
from 98109
Jalisco,
Click here to add this to my saved trials
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2417
mi
from 98109
Brick, NJ
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2417
mi
from 98109
Brick, NJ
Click here to add this to my saved trials
Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
Integrated Dual Exercise and Lexiscan PET: IDEAL PET
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
Integrated Dual Exercise and Lexiscan PET: IDEAL PET
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
The Massachusetts General Hospital Optical Coherence Tomography Registry
The Massachusetts General Hospital Optical Coherence Tomography Registry
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
The Massachusetts General Hospital Optical Coherence Tomography Registry
The Massachusetts General Hospital Optical Coherence Tomography Registry
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Alaska Heart Institute
1429
mi
from 98109
Anchorage, AK
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Alaska Heart Institute
1429
mi
from 98109
Anchorage, AK
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Phoenix Heart, PLLC
1100
mi
from 98109
Glendale, AZ
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Phoenix Heart, PLLC
1100
mi
from 98109
Glendale, AZ
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Consultants, Ltd.
1107
mi
from 98109
Phoenix, AZ
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Consultants, Ltd.
1107
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Beaver Medical Group/Clinical Care Research
988
mi
from 98109
Banning, CA
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Beaver Medical Group/Clinical Care Research
988
mi
from 98109
Banning, CA
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Memorial Health System
1067
mi
from 98109
Colorado Springs, CO
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Memorial Health System
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Colorado Heart & Vascular
1020
mi
from 98109
Denver, CO
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Colorado Heart & Vascular
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Bay Area Cardiology Associates, P.A.
2533
mi
from 98109
Brandon, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Bay Area Cardiology Associates, P.A.
2533
mi
from 98109
Brandon, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Florida at Gainsville
2453
mi
from 98109
Gainesville, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Florida at Gainsville
2453
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Reliable Clinical Research
2731
mi
from 98109
Miami, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Reliable Clinical Research
2731
mi
from 98109
Miami, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Orlando Regional Medical Center
2547
mi
from 98109
Orlando, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Orlando Regional Medical Center
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Palm Beach Gardens Research Center
2684
mi
from 98109
Palm Beach Gardens, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Palm Beach Gardens Research Center
2684
mi
from 98109
Palm Beach Gardens, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Velella Research
2552
mi
from 98109
Sarasota, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Velella Research
2552
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Tallahassee Research Institute
2330
mi
from 98109
Tallahassee, FL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Tallahassee Research Institute
2330
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Georgia Heart Specialist
2209
mi
from 98109
Covington, GA
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Georgia Heart Specialist
2209
mi
from 98109
Covington, GA
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Northeast Georgia Heart Center
2181
mi
from 98109
Gainesville, GA
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Northeast Georgia Heart Center
2181
mi
from 98109
Gainesville, GA
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Chicago
1737
mi
from 98109
Chicago, IL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Chicago
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated:  12/31/1969
Advocate Medical Group
1733
mi
from 98109
Chicago, IL
PRE-DETERMINE Cohort Study
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Status: Enrolling
Updated: 12/31/1969
Advocate Medical Group
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials